Sector Chart Renovaro Inc.

Equities

RENB

US29350E1047

Delayed Nasdaq 01:00:00 2024-07-03 pm EDT 5-day change 1st Jan Change
1.58 USD +1.94% Intraday chart for Renovaro Inc. +0.64% -50.16%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
229M - - - - -
122B
113B
26.22B -
19.01B -
15.71B